Answers are grounded in this paper and cite their sources.
Having recently established a faecal microbiota transplantation (FMT) programme, we raise two points about Spector and Knight’s editorial on FMT.1 Firstly, despite the UK’s relatively permissive regulatory framework on FMT, we encountered considerable obstacles to establishing an NHS programme. Donor screening is expensive (>£500 (€703; $755)/screen/donor, repeated regularly). It is unclear …
No takes yet. Share an insight, caveat, or question.
Mullish et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: